DOW JONES21,151.56-765.60 -3.49%
S&P 5002,487.34-97.25 -3.76%
NASDAQ7,422.24-277.86 -3.61%

Auris Medical Reports Last Subject Had Last Treatment In Phase 1b Trial Of AM-201, Sees Data Early May

Benzinga · 03/05/2020 13:33